(Q56987074)

2

0 references

B Piergentili

3

0 references

F Trapani

4

0 references

A Cascavilla

5

0 references

R Manfredi

6

0 references

V Colangeli

7

0 references

P Viale

International Journal of STD & AIDS

8

0 references

language of work or name

English

0 references

publication date

January 2011

0 references

published in

0 references

volume

22

0 references

issue

1

0 references

page(s)

43-5

0 references

cites work

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Blood pressure control and components of the metabolic syndrome: the GOOD survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

HIV infection and the risk of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256

Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.010256